These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27585379)

  • 1. Are De Novo DQ Donor-Specific Antibodies the Key to Chronic Lung Allograft Dysfunction?
    Shenoy KV
    Am J Respir Crit Care Med; 2016 Sep; 194(5):534-5. PubMed ID: 27585379
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
    Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
    Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.
    Willicombe M; Brookes P; Sergeant R; Santos-Nunez E; Steggar C; Galliford J; McLean A; Cook TH; Cairns T; Roufosse C; Taube D
    Transplantation; 2012 Jul; 94(2):172-7. PubMed ID: 22735711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
    J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation.
    Cole RT; Gandhi J; Bray RA; Gebel HM; Morris A; McCue A; Yin M; Laskar SR; Book W; Jokhadar M; Smith A; Nguyen D; Vega JD; Gupta D
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28181305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terasaki Epitope Mismatch Burden Predicts the Development of De Novo DQ Donor-Specific Antibodies and are Associated With Adverse Allograft Outcomes.
    Willicombe M; Blow M; Santos-Nunez E; Freeman C; Brookes P; Taube D
    Transplantation; 2018 Jan; 102(1):127-134. PubMed ID: 28731902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
    Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
    Lee H; Min JW; Kim JI; Moon IS; Park KH; Yang CW; Chung BH; Oh EJ
    Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
    Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.
    Levine DJ; Glanville AR; Aboyoun C; Belperio J; Benden C; Berry GJ; Hachem R; Hayes D; Neil D; Reinsmoen NL; Snyder LD; Sweet S; Tyan D; Verleden G; Westall G; Yusen RD; Zamora M; Zeevi A
    J Heart Lung Transplant; 2016 Apr; 35(4):397-406. PubMed ID: 27044531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation.
    Islam AK; Sinha N; DeVos JM; Kaleekal TS; Jyothula SS; Teeter LD; Nguyen DTM; Eagar TN; Moore LW; Puppala M; Wong STC; Knight RJ; Frost AE; Graviss EA; Osama Gaber A
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated rejection of the pancreas allograft.
    Torrealba JR; Odorico J
    Transplantation; 2009 Jul; 88(2):292-3. PubMed ID: 19623030
    [No Abstract]   [Full Text] [Related]  

  • 15. Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.
    Butler CL; Valenzuela NM; Thomas KA; Reed EF
    J Immunol Res; 2017; 2017():7903471. PubMed ID: 28373996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation.
    Takahashi H; Kato T; Mizutani K; Terasaki P; Delacruz V; Tzakis AG; Ruiz P
    Clin Transpl; 2006; ():529-34. PubMed ID: 18365419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Specific HLA Antibodies: A Review of Data Published in 2016.
    Idica A; Everly MJ
    Clin Transpl; 2016; 32():13-22. PubMed ID: 28564519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful lung transplantation in the presence of pre-existing donor-specific cytotoxic HLA Class II antibodies.
    Lambeck AJ; Verschuuren EA; Bouwman I; Jongsma T; Roozendaal C; Bungener LB; van der Bij W; van den Berg AP; Erasmus ME; Timens W; Lems SP; Hepkema BG
    J Heart Lung Transplant; 2012 Dec; 31(12):1301-6. PubMed ID: 23079068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.